Jacobson Kenneth A, Ellis-Davies Graham C R
Laboratory of Bioorganic Chemistry, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.
JACS Au. 2024 Dec 20;5(1):3-16. doi: 10.1021/jacsau.4c00779. eCollection 2025 Jan 27.
Abraham Patchornik was born in 1926 in Ness Ziona, a town in Palestine founded by his great-grandfather Reuben Lehrer in 1883. He started to study chemistry as an undergraduate at the Hebrew University. However, this was interrupted by the war, and he completed his studies in various locations in West Jerusalem. From 1952 to 1956 Patchornik completed his PhD at the (new) Weizmann Institute of Science with Ephraim Katchalski. After a postdoc at the NIH, he returned to the Weizmann in 1958, when he joined the Department of Biophysics. In 1972-1979, he became chairman of the new Department of Organic Chemistry at the Weizmann, and his own research was geared toward applying creative chemistry to solve biological problems. Patchornik passed away in his hometown of Ness Ziona in 2014. Patchornik was a conceptual leader in peptide and polymer chemistry. Given the importance of selective functional group protection for the construction of oligomeric molecules, he became interested in using "nonstandard", orthogonal chemistry for this purpose, i.e. photosensitive protecting groups (PPGs) in place of thermal reactions. It was R.B. Woodward who suggested this strategy to Patchornik in 1965, while Patchornik was on sabbatical leave at Harvard. However, it was not until Patchornik returned to the Weizmann that this idea of a versatile PPG to enable multistep synthesis was realized. Here, we provide an account of the early photosensitive protecting groups that Patchornik and co-workers developed, and the immense impact they have had on various fields. In particular, we survey the use of PPGs in live cell physiology (i.e., caged compounds), and the development of gene chips via light-directed solid-phase synthesis. Further, we highlight recent work applying new PPGs for "photochemical delivery" of drugs, otherwise termed photopharmacology. Finally, we discuss the relationship between caged compounds and how contemporary neuroscience uses genetically encoded chromophores to control cell function.
亚伯拉罕·帕乔尔尼茨1926年出生于内斯齐奥纳,这是巴勒斯坦的一个城镇,由他的曾祖父鲁本·莱勒于1883年建立。他本科时在希伯来大学开始学习化学。然而,战争打断了他的学业,他在耶路撒冷西部的不同地方完成了学业。1952年至1956年,帕乔尔尼茨在(新成立的)魏茨曼科学研究所与埃弗拉伊姆·卡察尔斯基一起完成了博士学业。在美国国立卫生研究院做了博士后之后,他于1958年回到魏茨曼,当时他加入了生物物理系。1972年至1979年,他成为魏茨曼新成立的有机化学系主任,他自己的研究致力于应用创新化学来解决生物学问题。帕乔尔尼茨于2014年在家乡内斯齐奥纳去世。帕乔尔尼茨是肽和聚合物化学领域的概念领导者。鉴于选择性官能团保护对于构建寡聚分子的重要性,他开始对为此目的使用“非标准”的正交化学感兴趣,即使用光敏保护基团(PPG)来替代热反应。1965年,当帕乔尔尼茨在哈佛休假时,R.B.伍德沃德向他提出了这个策略。然而,直到帕乔尔尼茨回到魏茨曼,这种能够实现多步合成的通用PPG的想法才得以实现。在此,我们讲述了帕乔尔尼茨及其同事早期开发的光敏保护基团,以及它们对各个领域产生的巨大影响。特别是,我们考察了PPG在活细胞生理学中的应用(即笼形化合物),以及通过光导向固相合成开发基因芯片的情况。此外,我们强调了最近将新的PPG应用于药物“光化学递送”(即光药理学)的工作。最后,我们讨论了笼形化合物之间的关系,以及当代神经科学如何利用基因编码的发色团来控制细胞功能。